Citations

Showing 10 of 107901 citations.

International prognostic scoring system for Waldenström macroglobulinemia
Morel, Pierre , Duhamel, Alain, Gobbi, Paolo G., Dimopoulos, Meletios Α. , Dhodapkar, Madhav V. , McCoy, Jason , Crowley, John, Ocio, Enrique M. , García‐Sánz, Ramón , Leblond, Véronique , Kyle, Robert A. , Barlogie, Bart , Merlini, Giampaolo , Treon, Steven P. , Merlini, Giampaolo , Dimopoulos, Meletios A , Garcia-Sanz, Ramon , Ocio, Enrique M

Mayo Clinic

Blood | February 6, 2009 | Volume: 113 | Issue: 18 | Pages: 4163-4170

10.1182/blood-2008-08-174961 | PMID 19196866 Get It

Abstract Recently, many new drugs have been developed for the treatment of Waldenström macroglobulinemia (WM). To optimize the treatment according to the prognosis and to facilitate the comparison of trials, we developed an International Prognostic Scoring System for WM in a series of 587 patients with clearly defined criteria for diagnosis and for initiation of treatment. The median survival after treatment initiation was 87 months. Five adverse covariates were identified: advanced age (>65 years), hemoglobin less than or equal to 11.5 g/dL, platelet count less than or equal to 100 × 109/L, β2-microglobulin more than 3 mg/L, and serum monoclonal protein concentration more than 7.0 g/dL. Low-risk patients (27%) presented with no or 1 of the adverse characteristics and advanced age, intermediate-risk patients (38%) with 2 adverse characteristics or only advanced age, and high-risk patients (35%) with more than 2 adverse characteristics. Five-year survival rates were 87%, 68%, and 36%, respectively (P < .001). The ISSWM retained its prognostic significance in subgroups defined by age, treatment with alkylating agent, and purine analog. Thus, the ISSWM may provide a means to design risk-adapted studies. However, independent validation and new biologic markers may enhance its significance.
Laparoscopic Transdiaphragmatic Access to the Apex of the Left Ventricle of the Heart
Thompson, Jess L., Suri, Rakesh M. , McKellar, Stephen H. , Schaff, Hartzell V. , Schaff, Hartzell

Mayo Clinic

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | February 5, 2009 | Volume: 4 | Issue: 1 | Pages: 27-31

10.1097/imi.0b013e318198779a | PMID 22436900 Get It

Objective Delivery of a collapsable aortic valve prosthesis via the left ventricular (LV) apex has proven problematic clinically. We describe our experience with a novel technique for a laparoscopic transdiaphragmatic approach to the LV outflow tract (LVOT). Methods Laparoscopic transabdominal access to the left ventricle was achieved in four live swine and one human cadaver using three abdominal laparoscopic trocars. Pericardioscopy and cardioscopy were performed. A hemostatic purse-string suture was placed laparoscopically at the apex of the left ventricle in one pig, and an instrument passed through the purse-string and into the LVOT. After the procedure, a thoracotomy was performed and the heart explanted for gross examination. Results Transdiaphragmatic exposure of the LV apex was accomplished at a mean of 23 minutes. Hemodynamic stability was maintained in all animals and the pleural cavities were not violated. Pericardioscopy allowed visualization of both right and left pulmonary veins along with the left atrial appendage. In situ cardioscopy confirmed that access to the LVOT and the aortic annulus was possible from the LV apex entry site. Conclusions Laparoscopic transdiaphragmatic approach to the LVOT is a possible route for minimally invasive beating heart aortic valve implantation. This strategy permits a straight transapical line of access to the aortic valve; avoiding the potential for cardiac torsion via a thoracotomy.
Comparison of the Abbott RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test: Workflow, Reliability, and Direct Costs
Sloma, Cari R., Germer, Jeffrey J., Gerads, Tara M., Mandrekar, Jayawant N. , Mitchell, P. Shawn, Yao, Joseph D.

Mayo Clinic

Journal of Clinical Microbiology | February 5, 2009 | Volume: 47 | Issue: 4 | Pages: 889-895

10.1128/jcm.02231-08 | PMID 19193837 Get It

ABSTRACT The Abbott RealTime human immunodeficiency virus type 1 (HIV-1) assay (ART) and the Cobas AmpliPrep/Cobas TaqMan HIV-1 test (CTM) are commercially available assays for quantification of HIV-1 RNA in plasma. We evaluated performance characteristics, workflow, throughput, reliability, and direct costs of these assays. Both assays yielded good correlation of quantitative results ( r = 0.95) among clinical specimens, with a mean difference of −0.34 log 10 copies/ml. Testing of healthy donor plasma specimens yielded “target not detected” results by ART, with “HIV-1 RNA detected, <40 copies/ml” results for 3.3% (3 of 90 samples) of these specimens by CTM. Both the m2000sp/m2000rt (ART) and docked CAP/CTM96 (CTM) instrument systems were capable of operating with continuous, uninterrupted workflow. When daily maintenance and cleaning were included, ART and CTM run durations (5 h 52 min and 6 h 4 min, respectively) and hands-on times (53 min and 46 min, respectively) were similar for a run batch size of 24. While ART was more flexible in terms of run batch size, CTM required fewer user interventions and consistently produced higher specimen throughput rates at 8, 16, and 24 h. Assay run failure rates were 6.3% (1 of 16 runs) and 4.2% (1 of 24 runs) for ART and CTM, respectively ( P = 1.000), with invalid specimen result rates of 1.0% (5 of 495 specimens) and 2.8% (11 of 399 specimens), respectively ( P = 0.073). Direct reagent and consumable costs for each assay were comparable (difference of <10%). In selecting an assay for implementation, laboratories should consider how various assay and instrument features might impact laboratory operation and patient care.
Ziliopathien
Czarnecki, Peter G. , Harris, Peter C.

Mayo Clinic

Medizinische Genetik | February 4, 2009 | Volume: 21 | Issue: 1 | Pages: 14-20

10.1007/s11825-009-0144-0 Get It

Zusammenfassung Zilien erfüllen viele unterschiedliche Funktionen, sie dienen als Mechano-, Chemo- und Osmosensoren und spielen bei zahlreichen Signalwegen, für eine adäquate Organentwicklung, für die Aufrechterhaltung der Gewebehomöostase und bei grundsätzlichen Entwicklungsprozessen eine wichtige Rolle. Die meisten Zelltypen im Körper weisen primäre Zilien auf, motile Zilien kommen v. a. im Respirationstrakt, ependymal in den Hirnventrikeln sowie auf Eileiterepithelien vor. Mit einem Funktionsverlust der Zilien einhergehende Krankheiten werden als Ziliopathien bezeichnet. Im vorliegenden Beitrag werden einige Erkrankungen, wie die primäre ziliäre Dyskinesie (PCD) oder polyzystische Nierenerkrankungen (PKD) und hier insbesondere die ADPKD (autosomal-dominante PKD), vorgestellt. Zudem werden die bisher identifizierten Gene, die bei der Pathogenese von Ziliopathien eine Rolle spielen, vorgestellt. Dabei verursachen viele der Genmutationen mehr als nur eine Erkrankung, und viele der aufgeführten Merkmale kommen bei verschiedenen Krankheiten vor.
Novel Mechanisms in the Regulation of Phosphorus Homeostasis
Berndt, Theresa J., Kumar, Rajiv

Mayo Clinic

Physiology | February 4, 2009 | Volume: 24 | Issue: 1 | Pages: 17-25

10.1152/physiol.00034.2008 | PMID 19196648 Get It

Phosphorus plays a critical role in diverse biological processes, and, therefore, the regulation of phosphorus balance and homeostasis are critical to the well being of the organism. Changes in environmental, dietary, and serum concentrations of inorganic phosphorus are detected by sensors that elicit changes in cellular function and alter the efficiency by which phosphorus is conserved. Short-term, post-cibal responses that occur independently of hormones previously thought to be important in phosphorus homeostasis may play a larger role than previously appreciated in the regulation of phosphorus homeostasis. Several hormones and regulatory factors such as the vitamin D endocrine system, parathyroid hormone, and the phosphatonins (FGF-23, sFRP-4, MEPE) among others, may play a role only in the long-term regulation of phosphorus homeostasis. In this review, we discuss how organisms sense changes in phosphate concentrations and how changes in hormonal factors result in the conservation or excretion of phosphorus.
Insulin Receptor Substrate-2 Mediated Insulin-like Growth Factor-I Receptor Overexpression in Pancreatic Adenocarcinoma through Protein Kinase Cδ
Kwon, Junhye, Stephan, Susann, Mukhopadhyay, Ananya, Muders, Michael H. , Dutta, Shamit K., Lau, Julie S., Mukhopadhyay, Debabrata

Mayo Clinic

Cancer Research | February 4, 2009 | Volume: 69 | Issue: 4 | Pages: 1350-1357

10.1158/0008-5472.can-08-1328 | PMID 19190347 Get It

Abstract Pancreatic adenocarcinoma (PCA) is an almost invariably fatal disease. Recently, it has been shown by several groups as well as ours that insulin-like growth factor-I receptor (IGF-IR) overexpression is related to higher proliferation, survival, angiogenesis, and highly invasive pancreatic tumors. Several studies have been carried out to understand the pathways that lead to growth factor–mediated signaling, but the molecular mechanism of receptor overexpression remains mostly unknown. Treatment with neutralizing antibodies or a specific kinase inhibitor against IGF-IR could block the receptor expression in PCA cells. Furthermore, we also showed that insulin receptor substrate (IRS)-2, but not IRS-1, is involved in regulation of IGF-IR expression, which is most likely not transcriptional control. By blocking mammalian target of rapamycin (mTOR) pathway with rapamycin as well as other biochemical analysis, we defined a unique regulation of IGF-IR expression mediated by protein kinase Cδ (PKCδ) and mTOR pathway. Moreover, we showed that the down-regulation of IGF-IR expression due to IRS-2 small interfering RNA can be compensated by overexpression of dominant-active mutant of PKCδ, suggesting that PKCδ is downstream of IGF-IR/IRS-2 axis. Overall, these findings suggest a novel regulatory role of IRS-2 on the expression of IGF-IR through PKCδ and mTOR in pancreatic cancer cells. [Cancer Res 2009;69(4):1350–7]
Neural Stem Cell– and Schwann Cell–Loaded Biodegradable Polymer Scaffolds Support Axonal Regeneration in the Transected Spinal Cord
Olson, Heather E. , Rooney, Gemma E., Gross, LouAnn, Nesbitt, Jarred J., Galvin, Katherine E., Chen, BingKun, Yaszemski, Michael J. , Windebank, Anthony J. , Knight, Andrew Michael

Mayo Clinic

Tissue Engineering Part A | February 3, 2009 | Volume: 15 | Issue: 7 | Pages: 1797-1805

10.1089/ten.tea.2008.0364 | PMID 19191513 Get It

Severity of Myocardial Infarction
Roger, Véronique L.

Mayo Clinic

Circulation | February 2, 2009 | Volume: 119 | Issue: 4 | Pages: 489-491

10.1161/circulationaha.108.829663 | PMID 19188517 Get It

Response to Letter Regarding Article, “Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy”
Sorajja, Paul , Valeti, Uma, Ommen, Steve R. , Rihal, Charanjit S. , Holmes, David R. , Hodge, David O. , Sorajja, Paul , Nishimura, Rick A. , Rihal, Charanjit S. , Gersh, Bernard J. , Schaff, Hartzell V.

Mayo Clinic

Circulation | February 2, 2009 | Volume: 119 | Issue: 4 | Pages: No page available

10.1161/circulationaha.108.819813 Get It

Carbohydrate Dependent Targeting of Cancer Cells by Bleomycin−Microbubble Conjugates
Chapuis, Jean-Charles, Schmaltz, Ryan M., Tsosie, Krystal S. , Bëlohlávek, Marek , Chapuis, Jean‐Charles, Hecht, Sidney M.

Mayo Clinic

Journal of the American Chemical Society | February 2, 2009 | Volume: 131 | Issue: 7 | Pages: 2438-2439

10.1021/ja8091104 | PMID 19187019 Get It